These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31083176)

  • 1. GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.
    Sun Q; Yuan F; Yuan R; Ren D; Zhu Y; Bi Y; Hu J; Guo Z; Xu F; Niu W; Ma G; Wu X; Yang F; Wang L; Li X; Yu T; He L; He G
    Medicine (Baltimore); 2019 May; 98(19):e15456. PubMed ID: 31083176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants in GRIK4 and major depressive disorder: An association study in the Chinese Han population.
    Ren D; Bi Y; Xu F; Niu W; Zhang R; Hu J; Guo Z; Wu X; Cao Y; Huang X; Yang F; Wang L; Li W; Xu Y; He L; Yu T; He G; Li X
    Neurosci Lett; 2017 Jul; 653():239-243. PubMed ID: 28583584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
    Zhu Y; Zhang N; Ren D; Bi Y; Xu F; Niu W; Sun Q; Guo Z; Yuan R; Yuan F; Wu X; Cao Y; Yang F; Wang L; Du L; Li W; Xu Y; Li X; Zhu L; He L; Shi L; He G; Yu T
    Clin Neuropharmacol; 2019; 42(2):32-36. PubMed ID: 30875344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.
    Zhang N; Ji L; Chen Z; An L; Ren D; Bi Y; Guo Z; Yuan R; Yuan F; Dong Z; Yin L; Sun X; Yang F; Li X; Yu T; He L; Shi L; He G
    Psychiatr Genet; 2020 Feb; 30(1):30-33. PubMed ID: 31842058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.
    Yuan F; Yuan R; Ren D; Bi Y; Niu W; Guo Z; Wu X; Xu F; Sun Q; Ma G; Yang F; Zhu Y; Yu T; Li X; He L; Shi L; He G
    Psychiatry Res; 2020 Feb; 284():112690. PubMed ID: 31757642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population.
    Li W; Ju K; Li Z; He K; Chen J; Wang Q; Yang B; An L; Feng G; Sun W; Zhou J; Zhang S; Song P; Khan RAW; Ji W; Shi Y
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):136-146. PubMed ID: 26655190
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sun Q; Yuan F; Ren D; Ma G; Yang F; Wu X; He L; He G
    Neuropsychiatr Dis Treat; 2019; 15():657-661. PubMed ID: 30880991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
    Yeh YW; Chen CJ; Jang FL; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Shyu JF; Wan FJ; Lu RB; Huang SY
    J Psychiatr Res; 2015 Feb; 61():33-9. PubMed ID: 25512257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.
    Wu N; Liu L; Ren D; Yuan F; Bi Y; Guo Z; Hou B; Ji L; Han K; Feng M; Su K; Yu T; Li X; Yang F; Sun X; Dong Z; Yu S; Yi Z; Xu Y; He L; Wu S; Zhao L; Changqun C; Shi Y; He G
    Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):53-56. PubMed ID: 33480616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of GRM7 polymorphisms with major depressive disorder in the Chinese Han population.
    Niu W; Huang X; Yu T; Chen S; Li X; Wu X; Cao Y; Zhang R; Bi Y; Yang F; Wang L; Li W; Xu Y; He L; He G
    Psychiatr Genet; 2017 Apr; 27(2):78-79. PubMed ID: 28027116
    [No Abstract]   [Full Text] [Related]  

  • 11. Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population.
    Niu W; Huang X; Yu T; Chen S; Li X; Wu X; Cao Y; Zhang R; Bi Y; Yang F; Wang L; Li W; Xu Y; He L; He G
    Neurosci Lett; 2015 Sep; 604():109-12. PubMed ID: 26254163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of GRIK4 gene in treatment-resistant depression.
    Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
    Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of GRIK4 gene polymorphisms on cognitive dysfunction in patients with major depression.
    Pu M; Wang X; Zhang J
    Rev Neurol (Paris); 2020 Dec; 176(10):823-828. PubMed ID: 32245654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.
    Chiesa A; Lia L; Lia C; Lee SJ; Han C; Patkar AA; Pae CU; Serretti A
    J Int Med Res; 2013 Jun; 41(3):809-15. PubMed ID: 23613500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population.
    Li Z; He Z; Tang W; Tang R; Huang K; Xu Z; Xu Y; Li L; Li X; Feng G; He L; Shi Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):876-80. PubMed ID: 18289755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.
    Li Z; Qi D; Chen J; Zhang C; Yi Z; Yuan C; Wang Z; Hong W; Yu S; Cui D; Fang Y
    Psychoneuroendocrinology; 2013 Jan; 38(1):107-14. PubMed ID: 22683211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
    Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
    Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder.
    Noroozi R; Taheri M; Omrani MD; Ghafouri-Fard S
    Neurochem Int; 2019 Oct; 129():104483. PubMed ID: 31170425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
    Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.
    Fabbri C; Drago A; Serretti A
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):612-21. PubMed ID: 22884879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.